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ABSTRACT 
COFFEE AND TEA INTAKE AND THE RISK OF CUTANEOUS MELANOMA 
MAY 2013 
Haotian Wu, B.S., UNIVERSITY OF OTTAWA 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Susan R. Sturgeon 
 
Cutaneous melanoma accounts for less than 5% of all skin cancers but over 75% of skin 
cancer related deaths. Prior biologic research suggests caffeine may arrest cancer cell 
formation and metastasis in vivo. Additionally, certain tea components exhibit anti-
inflammatory, anti-oxidant, and other anti-carcinogenic effects. Prior epidemiologic 
studies show possible protective effect of both coffee and tea on risk of melanoma, but 
results remain inconsistent. We examined the association between coffee and tea intake 
and risk of cutaneous melanoma using the Women’s Health Initiative Observational 
Study. Coffee and tea intake were measured through self-administered questionnaires. 
Melanomas were self-reported and physician adjudicated. Cox proportional hazards 
models were used to evaluate associations. Of the 66,484 white post-menopausal 
women with no prior history of cancer (average follow up=7.8 years), 73% reported daily 
intake of coffee, 26% reported daily tea intake, and 398 cases of melanoma were 
adjudicated. Daily coffee intake (HR=0.84 95% CI=0.66-1.08) and daily tea intake 
(HR=1.00, 95% CI=0.78-1.29) were not significantly associated with increased risk of 
cutaneous melanoma compared to non-daily intake. No significant trend was observed 
with increased daily coffee (p-trend=0.22) or tea intake (p-trend=0.28). In conclusion, we 
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observed insignificant inverse associations between coffee intake and cutaneous 
melanoma among post-menopausal Caucasian women. 
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CHAPTER 1 
INTRODUCTION 
 
Cutaneous melanoma is the cancer of skin melanocytes (1). It is the most 
serious skin cancer and its incidence is rising in the United States (1, 2). The overall rate 
in the U.S. was 19.77 cases per 100,000 White women from 2005 to 2009. During the 
same period, incidence of melanoma has increased by 2.3% per year (2-4). Older 
women are at especially high risk. White women ages 50 and above have rates ranging 
from 29-49 cases per 100,000 per year from 2005 to 2009, compared to women 24 or 
younger, who have less than 10 cases per 100,000 per year (4). It is estimated that 
cutaneous melanoma accounts for over 75% of all skin cancer related deaths (5). 
Cutaneous melanoma is highly resistant to both chemotherapy and radiation (1). A 
disproportionately large number of deaths due to cutaneous melanoma will be among 
older women (4).  
Environmental factors such as sunlight exposure and ultraviolet radiation 
exposure are major risk factors for cutaneous melanomas (1). Thus, depletion of the 
ozone, increased use of indoor UV tanning beds, and changes in behavior are 
suspected to contribute to the increasing incidence of melanoma (1). Hereditary risk 
factors include race/skin color, freckles, eye color, hair color, sunburns, and moles (1, 6). 
Factors such as photosensitive drugs, cosmetics, and artificial ultraviolet radiation 
exposure are also linked to cutaneous melanoma (1). With the incidence on the rise, it is 
important to study modifiable potential risk or protective factors aside from environmental 
or genetic exposures.  
While not well understood, it has been theorized that caffeine and tea 
components may both influence cutaneous melanoma development and metastasis (7-
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14). Caffeine has been found to be anti-carcinogenic in non-cutaneous melanoma and 
non-melanoma skin cancers in mice and in vitro (8-11). Tea components are also found 
to have various anti-carcinogenic effects in melanocytes in vitro, including antioxidant, 
anti-inflammatory, epigenetic changes, DNA repair, and immune system activation 
effects (12-14).  
In earlier epidemiologic studies, higher coffee consumption was linked to a 
decreased risk for cutaneous melanoma. However, later results found either null 
associations or evidence suggesting higher coffee intake was linked to higher risk for 
cutaneous melanoma (14-19). The only prospective epidemiologic study to examine the 
relationship between tea intake and melanoma risk found null associations, but case 
control studies suggested both positive and inverse associations (14, 17-19).  
Therefore, our study used data from the Women’s Health Initiative – 
Observational Study (WHI-OS), a prospective cohort of post-menopausal women 
gathered from 40 clinical centers throughout the US, to assess the impact of tea and 
coffee on the risk of melanoma.  
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CHAPTER 2 
METHODS 
 
2.1 Study Population  
The WHI-OS is a large multi-center, ethnically diverse prospective cohort study. 
WHI-OS recruited 93,676 women at 40 centers in the United States between October 
1st, 1993 and December 1st, 1998 (20). Post-menopausal women aged 50-79 who were 
ineligible or unwilling to participate in the Women’s Health Initiative - Controlled Trial 
(WHI-CT), had expected survival time greater than 3 years, and were not enrolled in 
another study, were eligible to participate in the WHI-OS (20). We accessed publicly 
available data with follow up through September 12, 2005.  
Of the original 93,676 participants with available data, participants were excluded 
if they were not self-reported as white (n=15,660) or reported having had a previous 
cancer (except non-melanoma skin cancer) (n=11,183). Additionally, 349 participants 
were excluded if they had no follow up information. No women were missing all 
exposure variables. Our primary analysis included 66,484 participants who contributed a 
total of 513,650 person-years of follow up. The average follow up among the 66,484 
participants was 7.73 years.  
 
2.2 Data Collection 
All covariates were collected with structured self-reported questionnaires, 
interviews, or physical exams. All covariates were collected at baseline screening visits, 
except sun exposure variables. Sun exposure variables were collected four years after 
study entry. Participants reported average daily time spent in the sun (<30 minutes, 30-
120 minutes, >120 minutes) during the summer and separately for other seasons during 
the year, in their childhood, teens, thirties, and their current age. Information on regular 
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sun screen use and skin reaction to sun exposure after 45-60 minutes were also 
collected. We conducted sensitivity analyses to examine the effect of sun exposure 
variables within our study.  
Information on coffee and tea intake was collected with baseline observational 
study questionnaire, year 3 follow up questionnaire, and year 6 follow up questionnaire. 
Participants were asked “Do you usually drink coffee each day?” on the baseline 
observational study questionnaire. Participants who answered “yes” indicated the 
number of cups of coffee per day: None, 1 cup/day, 2-3 cups/day, 4-5 cups/day, or 6 or 
more cups/day. Similar questions were asked for tea and de-caffeinated coffee. At year 
3 follow up, participants were asked “during the past 3 months, how often did you drink 
these beverages” and were given a list including “regular instant coffee”, “regular 
espresso or latte”, “other regular drip coffee”, “decaf coffee”, “regular tea”, and “herbal 
tea”. The participants were given the choices, Never or less than once per month, 1-
3/month, 1/week, 2-4/week, 5-6/week, 1/day, 2-3/day, 4-5/day, or 6+ per day. Similar 
questions were asked at year 6. Subdivisions of coffee beverages reported in years 3 
and 6 were combined to form categories to match baseline questionnaire. Similarly, 
regular and herbal tea information were combined. Primary exposures were defined as 
total coffee intake, caffeinated coffee intake, decaffeinated coffee intake, and total tea 
intake. For all exposures, both dichotomous and categorical variables were created. For 
dichotomous variables, participants were classified as either “less than 1 cup per day” or 
“1 or more cups per day”. For categorical variables of coffee, participants were classified 
into “less than 1 cup per day”, “1 cup per day”, “2-3 cups per day”, or “4 or more cups 
per day”. For categorical variables of tea, participants were classified into “less than 1 
cup per day”, “1 cup per day”, or “2 or more cups per day”.  
Cutaneous melanoma cases were defined as women who had an adjudicated 
diagnosis of cutaneous melanoma for the duration of follow up (24). Potential cases 
5 
 
were identified through self-reported annual questionnaires on various medical 
outcomes including melanoma or at a clinic visit at year 3 of follow up (24). Melanoma 
diagnoses were locally adjudicated until March 31, 2005. After March 31, 2005, all 
diagnoses were centrally adjudicated at the Clinical Coordinating Center in Seattle, 
Washington. A total of 398 cases were included in our primary analyses.  
 
2.3 Statistical Analysis  
Baseline characteristics of participants were compared by cups of total coffee, 
caffeinated coffee, decaffeinated coffee, and tea consumption using chi-squared tests. 
Cox proportional hazards were used to estimate hazard ratios (HR) and 95% confidence 
intervals (CI). Potential confounders associated with coffee consumption as well as risk 
factors for cutaneous melanoma were considered, including: age (50-54, 55-59, 60-69, 
70-79), body mass index (<25 kg/m2, 25-29.99 kg/m2, 30+ kg/m2), alcohol (none, <3 
drinks/week, 3-7 drinks/week, 7+ drinks/week), recreational physical activity (none, <60 
minutes/day, 60-150 minutes/day, >150 minutes/day), height (quartiles), waist-hip ratio 
(tertiles), education (high school or less, some college, undergraduate degree, graduate 
degree), income (<$20,000, $20,000-$49,999, $50,000-$99,999, >$100,000), region of 
residence (Northeast, South, Midwest, West), hormone use (ever, never), smoke (never, 
past, current), aspirin use (yes/no), sunscreen use (yes/no), skin reaction to sun (no 
burn/tan, burn/tan, burn/tan slightly, burn/no tan), childhood sun exposure (<=120 
minutes/day, >120 minutes/day), teenage sun exposure (<=120 minutes/day, >120 
minutes/day), and thirties sun exposure (<=120 minutes/day, >120 minutes/day).  
To select for covariates, we used the Hosmer-Lemeshow purposeful selection. 
Covariates were included in the crude multivariate model if they scored p<0.25 in 
univariate Cox models.  
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Starting with variables with the highest p-values from the Wald test, a formal log 
likelihood ratio test was conducted to determine inclusion of variables in the final model. 
Those with log-likelihood ratio test p-values <0.05 were included.  
We conducted sensitivity analyses restricting the study population to those who were 
concordant in their reporting of coffee and tea intake between baseline and year 3 follow 
up. For this analysis, follow up started at year 3, participants who developed melanoma, 
dropped out, or died before year 3 were not included. Further analysis restricting to year 
4 and beyond to test for effect of post-hoc collection of sun exposure variables was 
conducted. For this analysis, follow up started at year 4, and participants who developed 
melanoma, dropped out, or died before year 4 were excluded. The proportional hazards 
assumption was tested by dividing follow up time to yearly segments (i.e. year 0-1, year 
1-2, year 2-3, etc.). For primary analyses, follow up time accrued from enrollment to date 
of diagnosis, death, or last date of follow up, whichever one was first. For time-period 
specific analysis, individuals who developed cutaneous melanoma, dropped out, or died 
prior to start of time period were excluded from analysis.  
Two-sided p-values <0.05 were considered statistically significant. All analyses 
were performed using Stata 12.0 (College Station, Tx) and SAS 9.3 (Cary, NC). 
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CHAPER 3 
RESULTS 
 
After excluding women who were not Caucasian and those who had history of 
prior cancer(s) (except non-melanoma skin cancers), 66,484 women and 513,650 
person-years were available for primary analyses. The average age of the population 
was 63.6 years old at baseline and average follow up was 7.7 years. A total of 398 
cases of cutaneous melanoma were reported, of which 292 occurred in women without a 
history of non-melanoma skin cancer.  
Table 1 shows the consumption of coffee at baseline. 73.23% women reported 
taking at least one cup of coffee per day, 26.71% reported less than one cup of coffee 
per day, and 0.06% were missing coffee intake information. Of the 73.23% with at least 
1 cup per day, 13.95% reported exactly 1 cup per day, 33.85% reported 2-3 cups per 
day, and 23.65% reported 4 or more cups per day. The women then further indicated the 
amount of caffeinated and de-caffeinated coffee consumption. 41.92% women reported 
less than 1 cup of caffeinated coffee per day, 16.88% reported exactly 1 cup per day, 
30.53% reported 2-3 cups per day, and 10.67% reported 4 or more cups per day. 
65.08% reported less than 1 cup of decaffeinated coffee per day, 14.88% reported 
exactly 1 cup per day, 13.97% reported 2-3 cups per day, and 3.55% reported 4 or more 
cups per day. For overall tea intake, 73.11% reported less than 1 cup per day, 12.36% 
reported exactly 1 cup, and 13.14% reported 2 or more cups per day.  
There were significant differences in distribution of covariates among the coffee 
exposure groups (Table 2). Those who drank coffee were less likely to be obese 
(p<0.001) and have lower waist-hip ratio (p<0.001), though there were no clear 
differences in exercise. Not surprisingly, those who drank coffee were more likely to 
drink more alcohol (p<0.001), take aspirin (p<0.001), and be either past or current 
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smokers (p<0.001). Women who drank coffee were also slightly more likely to report 
spending more than 2 hours per day outside during the summer in their thirties 
(p<0.001), though no clear differences were observed in other sun exposure covariates 
(sunscreen use, skin reaction to sun, time spent outside during other periods). There 
were some small differences in distribution of region of residence, as high coffee 
consumers were less likely to live in the West. Most of the other significant differences in 
covariates were small and do not follow any patterns (Table 2). Distribution of covariates 
among tea exposure groups was similar compared to coffee (Appendix A). Table 3 
shows the age adjusted hazard ratios of covariates.  
Table 4 shows age and multivariate adjusted hazard ratios. Drinking 1 or more 
cups of coffee per day showed an insignificant 16% lower risk compared to those who 
drank less than 1 cup of coffee per day (HR=0.84 95% CI=0.66-1.08). There was no 
dose response observed for overall coffee intake. Those who reported exactly 1 cup of 
total coffee, 2-3 cups, and 4 or more cups showed 11%, 15%, and 17% decrease in risk 
of cutaneous melanoma (p-trend=0.22). Daily intake of caffeinated (HR=0.94 95% 
CI=0.75-1.18) and decaffeinated coffee (HR=0.86 95% CI=0.68-1.09) also showed 
insignificant decreases in risk of cutaneous melanoma. There were no consistent trends 
for either caffeinated (p-trend=0.92) or de-caffeinated coffee (p-trend=0.34) intake. Daily 
tea intake was not associated with risk of cutaneous melanoma (HR=1.00 95% CI=0.78-
1.29). There was also no trend observed for tea intake (p-trend=0.28).  
Assessment of sunlight exposure and risk of cutaneous melanoma is shown on 
Table 5. Follow up was restricted to year 4 and beyond and the effects of sunlight 
variables were tested against the age adjusted model. Coffee and tea intake were 
updated with year 3 follow up. The inclusion of sun exposure covariates did not 
appreciably change any hazard ratio estimates between coffee and tea intake and risk of 
melanoma. The hazard estimate for daily coffee and risk of melanoma remained at 0.73 
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when region, sunscreen use, skin reaction to sun exposure, and average summer time 
outdoors in the thirties and last year were added to the model.  
Table 6 assessed the hazard ratios for daily coffee intake over time. Follow-up 
time was divided into yearly segments, with maximum follow-up of 1 year in any given 
segment, except for year 7 and beyond. Participants were excluded if they had dropped 
out, died, or had melanoma diagnosis prior to start of segment. Exposure levels during 
each segment were updated with the most up to date information. For example, people 
would be included in analysis for time period 3-4 if they had available intake data from 
year 3 follow up and did not drop out or have event prior to year 3. Hazard ratio 
estimates changed considerably over time. Higher coffee intake increased risk of 
melanoma years 1 and 3 of follow up then showed a decreased risk in all other 
segments.  
Table 7 shows results when restricting to only those who were concordant in their 
reporting of coffee and tea intake between baseline and year 3. When restricted to after 
year 4, those who reported at least one cup of coffee per day at both baseline and year 
3 show a significant 44% decrease in risk of melanoma compared to those who reported 
less than one cup of coffee per day in both (HR=0.66, 95% CI=0.46-0.96). No downward 
trend in risk was observed (p=0.11) with increased coffee intake. Concordant intake of 
caffeinated (HR=0.72 95% CI=0.51-1.03) and decaffeinated coffee (HR=0.79 95% 
CI=0.50-1.24) showed insignificant decreases in risk of cutaneous melanoma. There 
were also no downward trends in risk observed for either caffeinated (p-trend=0.28) or 
decaffeinated coffee (p-trend=0.15). Concordant daily tea drinking was not associated 
with the risk of melanoma (HR=1.05 95% CI=0.66-1.67). 
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CHAPTER 4 
DISCUSSION 
 
In our study of 66,484 post-menopausal women, no evidence of a significant 
protective effect by either coffee or tea intake with respect to risk of cutaneous 
melanoma was found. Additionally, no dose-response or threshold was observed for all 
exposure types and categories.  
Two recent prospective cohorts have found similar insignificant relationships 
between coffee and tea intake and risk of cutaneous melanoma, though they were 
suggestive of positive relationships (6, 14). Both studies had similar participant 
demographics compared to the WHI-OS. An 8 year prospective study of post-
menopausal women in Iowa by Zheng and colleagues showed an insignificant 11% 
increase in risk of cutaneous melanoma among high tea consumers (14). Song and 
colleagues reported a non-significant 31% increase in risk among those in the highest 
quartile of caffeine consumption (604 mg/day) compared to lowest quartile (31mg/day) in 
the Nurses’ Health Study (6). Case-control study results showed a wide range of results, 
ranging from strongly protective to positive relationships (17-19). Briefly, Österlind found 
decreased risk for high coffee consumers and increased risk for high tea consumers in 
Norwegians (18). Naldi found insignificant decreases in risk for both high coffee and high 
tea consumers in Italians (17). Fortes found an insignificant decrease in risk for high 
coffee consumers but a significant decrease in risk for high tea consumers in Italians 
(19).  
Discrepancy in results may be due to several differences. Song and colleagues 
used caffeine as exposure of interest, which includes not only coffee and tea, but also 
sodas and increasingly popular energy drinks (6). They were also able to examine a 
wider range of exposures with the lowest quartile having minimal average caffeine intake 
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(31 mg/day). It is possible that the threshold for a positive relationship between coffee 
and tea intake exists at a lower level than we can detect, as our lowest exposure group 
may still have a high amount of average caffeine intake. The Norwegian cohort and 
case-control study had very limited amount of melanoma cases and were not able to 
fully adjust for potential covariates. The Italian case-control studies both used hospital 
based populations of all ages and both gender. Therefore, they may not be able to 
generalize to our population of post-menopausal women.  
Our studies had several strengths. We had a large prospective cohort of women 
with a fairly long follow up, totaling over 500,000 person-years under analysis. As a 
result, we also had a large number of physician adjudicated incident cutaneous 
melanoma cases. Loss to follow up was minimal, reducing the likelihood of selection 
bias. We were able to examine the effects of caffeinated and decaffeinated coffee 
consumption and control for wide range of potential covariates. Study participants were 
fairly homogenous, with very little differences between groups for most covariates.  
There are also several limitations to our study. Coffee and tea intake data were 
self-reported and not collected consistently with the same questions. Differences in 
wording may have led to differential reporting of coffee and tea intake. As noted earlier, 
we could not distinguish between the true non-drinkers and low drinkers. There could be 
a difference between those who never drink coffee or tea and those who are not daily 
drinkers. Many potential covariates were adjusted for, but certain information such as 
family history, history of skin related conditions such as moles, and skin and eye colors 
was unavailable. Sun exposure data was available, however, it was not collected at 
baseline, but only at year 4 of follow up. While they demonstrated very little effect on 
overall hazard ratio estimates, these important covariates may have been potentially 
biased by recall. Surveillance bias may have been present. There were no significant 
overall effects but the hazard ratios were suggestive of a positive relationship before 
12 
 
sharply dropping to an inverse relationship. Such non-linear relationships are not 
expected given the duration of coffee intake among a cohort of older women. It is 
possible that some cases were diagnosed earlier in women with certain unhealthy 
lifestyle habits, which includes excessive coffee consumption. 
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CHAPTER 5 
CONCLUSION 
 
In conclusion, we are able to provide further evidence for the elucidation of the 
true relationship between coffee, tea, and cutaneous melanoma. Coffee and tea intake 
were not significantly associated with risk of cutaneous melanoma among post-
menopausal Caucasian women. However, it is still important to continue to study 
potential modifiable risk factors of cutaneous melanoma. 
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Table 1. Frequency of reported coffee and tea intake at baseline 
    Number % 
Total Coffee per Day (Cups) 
   <1 
 
17505 26.3 
1 
 
9275 14.0 
2-3 
 
22508 33.9 
4+ 
 
15724 23.7 
Missing 
 
1472 2.2 
Caffeinated Coffee per Day  
(Cups) 
   <1 
 
27761 41.9 
1 
 
11180 16.9 
2-3 
 
20223 30.5 
4+ 
 
7065 10.7 
Missing 
 
255 0.4 
Decaf Coffee per Day 
(Cups) 
   <1 
 
43268 65.1 
1 
 
9892 14.9 
2-3 
 
9291 14.0 
4+ 
 
2358 3.6 
Missing 
 
1675 2.5 
Tea per Day (Cups) 
   <1 
 
48609 73.1 
1 
 
8219 12.4 
2+ 
 
8741 13.1 
Missing 
 
915 1.4 
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Table 2. Distribution of covariates according to coffee consumption 
            <1 cup/day 1 cup/day 2-3 cups/day 4+ cups/day   
  N (%) N (%) N (%) N (%) P 
Age 
         50-54 2684 15.3 961 10.4 2679 11.9 2063 13.1 <0.001 
55-59 3463 19.8 1587 17.1 4025 17.9 3026 19.2 
 60-69 7369 42.1 4073 43.9 10225 45.4 7340 46.7 
 70-79 3989 22.8 2654 28.6 5579 24.8 3295 21.0 
 Education 
         high school or less 3065 17.7 1908 20.7 4631 20.7 3115 19.9 <0.001 
some college 6083 35.0 3360 36.5 8297 37.1 5719 36.6 
 bachelors 4493 25.9 2308 25.1 5370 24.0 3752 24.0 
 graduate degree 3721 21.4 1630 17.7 4062 18.2 3033 19.4 
 Income 
         <$20000 2181 13.4 1108 12.9 2756 13.1 1824 12.4 0.001 
$20000-49999 6891 42.4 3869 45.1 9226 44.0 6438 43.9 
 $50000-99999 5124 31.6 2605 30.3 6436 30.7 4693 32.0 
 >$100000 2045 12.6 1007 11.7 2549 12.2 1722 11.7 
 BMI (kg/m^2) 
        <25 7660 44.2 4007 43.7 9447 42.4 6601 42.4 <0.001 
25-29.99 5388 31.1 3115 34.0 7843 35.2 5558 35.7 
 30+ 4267 24.6 2045 22.3 4991 22.4 3408 21.9 
 WHR 
         <0.75 4455 25.6 2162 23.5 5561 24.8 4292 27.5 <0.001 
0.75-0.85 8724 50.1 4690 50.9 11429 51.1 7981 51.1 
 >0.85 4224 24.3 2369 25.7 5397 24.1 3359 21.5 
 Height 
         <158 (Q1) 4473 25.8 2654 28.9 5812 26.0 3708 23.8 <0.001 
158-162.1 (Q2) 4137 23.8 2251 24.5 5578 25.0 3835 24.6 
 162.2-166.3 (Q3) 4381 25.2 2244 24.4 5555 24.9 3967 25.4 
 >166.3 (Q4) 4377 25.2 2039 22.2 5396 24.2 4104 26.3 
 Alcohol 
         Non-Drinkers 8700 49.8 3522 38.0 6906 30.7 5017 31.9 <0.001 
<3 per week 5891 33.7 3355 36.2 8252 36.7 5760 36.7 
 3-7 per week 1457 8.3 1152 12.4 3418 15.2 2336 14.9 
 >7 per week 1437 8.2 1236 13.3 3911 17.4 2594 16.5 
 Exercise per week 
        None 2501 14.4 1356 14.7 3051 13.6 2137 13.6 0.003 
<60 minutes 2188 12.6 1201 13.0 2746 12.3 2031 13.0 
 60-150 minutes 3919 22.5 2169 23.5 5331 23.8 3657 23.4 
 >150 minutes 8823 50.6 4512 48.8 11280 50.3 7840 50.1 
 Region 
         Northeast 3968 22.7 2576 27.8 5927 26.3 3870 24.6 <0.001 
South 3953 22.6 2414 26.0 5527 24.6 3401 21.6 
 Midwest 4191 23.9 1775 19.1 5005 22.2 4312 27.4 
 West 5393 30.8 2510 27.1 6049 26.9 4141 26.3 
 Hormone Use 
        Never 4499 26.1 2431 26.6 6041 27.3 4553 29.5 <0.001 
16 
 
Ever 12720 73.9 6704 73.4 16101 72.7 10887 70.5 
 Smoke 
         Never 10540 60.8 5011 54.8 10256 46.2 6245 40.2 <0.001 
Past 6280 36.2 3833 41.9 10637 47.9 7681 49.5 
 Current 507 2.9 308 3.4 1321 6.0 1600 10.3 
 Any NSAID use 
        No 10240 58.5 5268 56.8 12610 56.0 8678 55.2 <0.001 
Yes 7265 41.5 4007 43.2 9897 44.0 7046 44.8 
 Aspirin 
         No 13806 78.9 7198 77.6 17373 77.2 12071 76.8 <0.001 
Yes 3699 21.1 2077 22.4 5134 22.8 3653 23.2 
 Sunscreen Use 
        No 7388 47.3 3890 47.0 9127 45.4 6644 47.2 0.001 
Yes 8236 52.7 4380 53.0 10958 54.6 7419 52.8 
 Skin Reaction 
        no burn/tan 5431 35.1 3065 37.4 7188 36.0 5128 36.5 <0.001 
burn/tan 3906 25.2 2046 24.9 5179 25.9 3594 25.6 
 burn/tan slightly 4226 27.3 2192 26.7 5425 27.2 3777 26.9 
 burn/no tan 1920 12.4 902 11.0 2184 10.9 1565 11.1 
 Summer/day during childhood 
       <=120 minutes 4503 28.5 2456 29.4 5721 28.2 4010 28.2 0.201 
>120 minutes 11279 71.5 5901 70.6 14554 71.8 10208 71.8 
 Summer/day during Teens 
       <=120 minutes 6502 41.2 3364 40.3 7852 38.8 5497 38.7 <0.001 
>120 minutes 9264 58.8 4980 59.7 12408 61.2 8700 61.3 
 Summer/day during thirties 
       <=120 minutes 10931 69.3 5707 68.3 13681 67.4 9566 67.3 <0.001 
>120 minutes 4845 30.7 2644 31.7 6604 32.6 4644 32.7 
 Other season/day during childhood 
      <=120 minutes 9966 63.4 5203 62.6 12800 63.4 8934 63.2 0.611 
>120 minutes 5748 36.6 3109 37.4 7404 36.7 5197 36.8 
 Other season/day during teens 
       <=120 minutes 11053 70.3 5747 69.1 14077 69.7 9859 69.7 0.255 
>120 minutes 4662 29.7 2568 30.9 6113 30.3 4280 30.3 
 Other season/day during thirties 
       <=120 minutes 13144 83.5 6882 82.7 16743 82.9 11733 82.9 0.310 
>120 minutes 2601 16.5 1442 17.3 3465 17.2 2419 17.1 
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Table 3. Age adjusted HRs for covariates and risk of 
melanoma 
  
Cases HR 95% CI p-value 
Age 
     50-54 
 
51 1 Ref 
 55-59 
 
74 1.03 0.72-1.47 0.87 
60-69 
 
187 1.14 0.83-1.47 0.42 
70-79 
 
86 1.00 0.71-1.42 0.99 
Education 
     high school or less 
 
42 1 Ref 
 some college 
 
124 1.59 1.12-2.26 0.01 
bachelors 
 
120 2.27 1.59-3.22 <0.01 
graduate degree 
 
106 2.56 1.78-3.66 <0.01 
Income 
     <20000 
 
24 1 Ref 
 20000-49999 
 
135 1.72 1.11-2.66 0.01 
50000-99999 
 
149 2.82 1.82-4.37 <0.01 
>100000 
 
68 3.43 2.13-5.53 <0.01 
BMI 
     <25 
 
187 1 Ref 
 25-29.99 
 
133 0.91 0.73-1.14 0.40 
30+ 
 
68 0.70 0.53-0.93 0.01 
WHR 
     <0.75 
 
122 1 Ref 
 0.75-1.00 
 
194 0.80 0.64-1.01 0.06 
>1.00 
 
81 0.73 0.55-0.98 0.03 
Height 
     <158 (Q1) 
 
79 1 Ref 
 158-162.1 (Q2) 
 
95 1.27 0.94-1.71 0.12 
162.2-166.3 (Q3) 
 
98 1.28 0.95-1.73 0.10 
>166.3 (Q4) 
 
118 0.58 1.18-2.12 <0.01 
Alcohol 
     Non-Drinkers 
 
96 1 Ref 
 <3 per week 
 
152 1.62 1.27-2.10 <0.01 
3-7 per week 
 
57 1.68 1.21-2.33 <0.01 
>7 per week 
 
93 2.53 1.90-3.36 <0.01 
Exercise per week 
     None 
 
44 1 Ref 
 <60 minutes 
 
45 1.11 0.73-1.68 0.62 
60-150 minutes 
 
85 1.13 0.78-1.62 0.52 
>150 minutes 
 
222 1.36 0.98-1.88 0.06 
Region 
     Northeast 
 
135 1 Ref 
 South 
 
81 0.64 0.49-0.85 <0.01 
Midwest 
 
71 0.58 0.43-0.77 <0.01 
West 
 
111 0.75 0.58-0.96 0.02 
Hormone Use 
     Never 
 
101 1 Ref 
 Ever 
 
291 1.08 0.86-1.35 0.52 
Smoke 
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Never 
 
183 1 Ref 
 Past 
 
194 1.20 0.98-1.47 0.08 
Current 
 
11 0.53 0.29-0.98 0.04 
Any NSAID use 
     No 
 
237 1 Ref 
 Yes 
 
161 0.90 0.74-1.10 0.31 
Aspirin 
     No 
 
323 1 Ref 
 Yes 
 
75 0.82 0.64-1.06 0.12 
Sunscreen Use 
     No 
 
93 1 Ref 
 Yes 
 
273 2.56 2.03-3.25 <0.01 
Skin Reaction 
     no burn/tan 
 
84 1 Ref 
 burn/tan 
 
89 1.52 1.12-2.05 0.01 
burn/tan slightly 
 
132 2.12 1.61-2.79 <0.01 
burn/no tan 
 
60 2.28 1.64-3.18 <0.01 
Summer/day during childhood 
   <=120 minutes 
 
93 1 Ref 
 >120 minutes 
 
279 1.20 0.95-1.52 0.13 
Summer/day during teens 
   <=120 minutes 
 
133 1 Ref 
 >120 minutes 
 
236 1.17 0.95-1.45 0.14 
Summer/day during thirties 
   <=120 minutes 
 
216 1 Ref 
 >120 minutes 
 
154 1.53 1.24-1.88 <0.01 
Other season/day during childhood 
  <=120 minutes 
 
223 1 Ref 
 >120 minutes 
 
147 1.14 0.93-1.40 0.22 
Other season/day during teens 
   <=120 minutes 
 
2523 1 Ref 
 >120 minutes 
 
116 1.07 0.86-1.33 0.54 
Other season/day during thirties 
  <=120 minutes 
 
301 1 Ref 
 >120 minutes 
 
69 1.13 0.87-1.46 0.38 
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Table 4. Adjusted hazards ratios for coffee and tea intake and risk of melanoma 
  Age Adjusted Multivariate Model 1* Multivariate Model 2ƚ 
  N
a
 
Person 
Years HR CI p N 
Person 
Years HR CI p N 
Person 
Years HR CI p 
Coffee 
               No 105 136846 1 Ref 
 
98 123313 1 Ref 
 
91 109153 1 Ref 
 Yes 293 376523 1.01 0.81-1.27 0.91 257 340249 0.89 0.70-1.13 0.34 226 302067 0.84 0.66-1.08 0.18 
Coffee (cups) 
              
<1 102 134955 1 Ref 
 
95 121678 1 Ref 
 
89 107767 
1 
(Ref) 
  1 54 70871 1.01 0.73-1.41 0.95 47 63521 0.89 0.63-1.26 0.50 44 56200 0.89 0.62-1.28 0.53 
2-3 137 173975 1.04 0.81-1.35 0.75 121 157465 0.91 0.69-1.20 0.50 107 139601 0.85 0.64-1.14 0.27 
4+ 94 122737 1.01 0.77-1.34 0.93 83 111243 0.91 0.67-1.23 0.52 71 99469 0.83 0.60-1.14 0.25 
     
0.86 
    
0.54 
    
0.22 
Regular 
               No 164 214256 1 Ref 
 
147 192888 1 Ref 
 
135 171260 1 Ref 
 Yes 234 297487 1.03 0.84-1.25 0.79 208 269253 0.98 0.79-1.22 0.88 182 238751 0.94 0.75-1.18 0.60 
Regular (cups) 
              <1 164 214256 1 Ref 
 
147 192888 1 Ref 
 
135 171260 1 Ref 
 1 62 85966 0.94 0.70-1.26 0.69 55 77627 0.87 0.64-1.19 0.39 51 68580 0.87 0.63-1.20 0.40 
2-3 129 156568 1.08 0.85-1.36 0.53 116 141887 1.03 0.80-1.32 0.83 100 126167 0.96 0.74-1.26 0.79 
4+ 43 54954 1.02 0.73-1.43 0.89 37 49740 1.05 0.73-1.51 0.80 31 44004 1.01 0.68-1.50 0.97 
     
0.62 
    
0.74 
    
0.91 
Decaf  
               No 252 333588 1 Ref 
 
229 301434 1 Ref 
 
209 267137 1 Ref 
 Yes 133 167472 1.05 0.85-1.30 0.64 115 15183 0.93 0.74-1.16 0.52 101 134847 0.86 0.68-1.09 0.22 
Decaf (cups) 
              <1 252 333588 1 Ref 
 
229 301434 1 Ref 
 
209 267137 1 Ref 
 1 57 76832 0.98 0.74-1.31 0.90 48 69209 0.84 0.62-1.15 0.28 43 61632 0.78 0.56-1.09 0.15 
2-3 67 72175 1.23 0.94-1.61 0.13 59 65425 1.09 0.82-1.46 0.55 50 58362 0.99 0.72-1.34 0.93 
4+ 9 18465 0.65 0.33-1.25 0.20 8 16548 0.63 0.31-1.27 0.20 8 14853 0.69 0.34-1.39 0.30 
     
0.75 
    
0.62 
    
0.34 
Tea (cups) 
              No 286 375840 1 Ref 
 
257 339406 1 Ref 
 
228 301659 1 Ref 
 Yes 108 134044 1.06 0.85-1.32 0.61 95 121002 1.01 0.80-1.28 0.92 87 106931 1.00 0.78-1.29 0.99 
Tea  
               <1 286 375840 1 Ref 
 
257 339406 1 Ref 
 
228 301659 1 Ref 
 1 40 63372 0.83 0.60-1.15 0.27 35 57340 0.76 0.53-1.09 0.13 30 50788 0.72 0.49-1.05 0.09 
2+ 64 67591 1.24 0.95-1.63 0.11 57 60923 1.24 0.93-1.66 0.14 54 53739 1.31 0.97-1.77 0.08 
          0.28         0.39         0.28 
a – Number of melanoma diagnoses in each group 
* - Adjusted for age, height, waist-hip ratio, education, income, alcohol, smoke, region, aspirin, and history of non-melanoma skin cancer 
ƚ - Adjusted for age, height, education, income, alcohol, smoke, region, aspirin, history of non-melanoma skin cancer, sunscreen use, skin reaction, summer sun exposure in 
thirties 
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Table 5. Adjusted hazard ratios of coffee and tea intake and risk of melanoma starting from year 4 
 Age Adjusted - 4+ year   Age and Sun Adjusted* 
    N
a
 HR CI p   N
a
 HR CI P 
Coffee           
No  75 1 Ref   70 1 Ref  
Yes  118 0.73 0.55-0.98 0.04  112 0.73 0.54-0.98 0.04 
Coffee (cups)          
<1  75 1 Ref   70 1 Ref  
1  30 0.74 0.48-1.13 0.16  30 0.77 0.50-1.19 0.24 
2-3  63 0.76 0.54-1.06 0.11  60 0.75 0.53-1.06 0.1 
4+  25 0.67 0.54-1.03 0.08  22 0.62 0.39-1.01 0.05 
     0.05     0.03 
Regular          
No  110 1 Ref   103 1 Ref  
Yes  84 0.77 0.58-1.02 0.07  80 0.78 0.58-1.04 0.10 
Regular (cups)         
<1  110 1 Ref   103 1 Ref  
1  25 0.75 0.49-1.17 0.21  25 0.80 0.52-1.24 0.31 
2-3  46 0.81 0.57-1.14 0.23  43 0.80 0.56-1.14 0.21 
4+  13 0.68 0.38-1.21 0.19  12 0.69 0.38-1.26 0.23 
     0.09     0.10 
Decaf           
No  151 1 Ref   143 1 Ref  
Yes  42 0.88 0.62-1.24 0.46  39 0.84 0.59-1.19 0.32 
Regular (cups)         
<1  151 1 Ref   143 1 Ref  
1  19 0.96 0.60-1.55 0.87  19 0.98 0.60-1.58 0.92 
2-3  21 0.92 0.58-1.45 0.72  18 0.81 0.49-1.32 0.39 
4+  2 0.39 0.10-1.57 0.18  2 0.41 0.10-1.64 0.21 
     0.30     0.17 
Tea           
No  136 1 Ref   127 1 Ref  
Yes  58 1.03 0.76-1.40 0.86  56 1.00 0.73-1.37 0.99 
Tea (cups)           
<1  136 1 Ref   127 1 Ref  
1  14 0.73 0.42-1.26 0.26  14 0.73 0.42-1.27 0.26 
2-3  44 1.19 0.84-1.66 0.33  42 1.14 0.81-1.62 0.45 
     0.49     0.62 
a – Number of melanoma diagnoses in each group 
*- Adjusted for age, region, skin reaction, sunscreen use, summer sun exposure in thirties and past year 
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Table 6. Adjusted hazard ratios for coffee in yearly segments 
    Daily Coffee*   Cups of Coffee per Day* 
     No Yes   <1 1 2-3 4+ 
 Year 0-1a 
 
1 (Ref) 1.11   1 (Ref) 0.79 1.62 1.10 
 Year 1-2a 
 
1 (Ref) 0.86   1 (Ref) 0.79 0.90 0.77 
 Year 2-3a 
 
1 (Ref) 1.74   1 (Ref) 2.13 1.52 1.69 
 Year 3-4b 
 
1 (Ref) 0.84   1 (Ref) 0.97 0.84 0.69 
 Year 4-5b 
 
1 (Ref) 0.69   1 (Ref) 0.33 0.96 0.52 
 Year 5-6b 
 
1 (Ref) 0.48   1 (Ref) 0.69 0.39 0.41 
 Year 6-7c 
 
1 (Ref) 0.86   1 (Ref) 1.48 0.66 0.72 
 Year 7+c   1 (Ref) 0.75   1 (Ref) 0.75 0.53 1.06 
 *- Adjusted for age, height, whr, education, income, alcohol, smoking, 
region, aspirin, history of non-melanoma skin cancer  
 a-baseline intake data           b-year 3 intake data         c - year 6 intake 
data 
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Table 7. Adjusted Hazards Ratios for coffee and tea intake and risk of 
melanoma starting from year 4 in concordant intakers 
  Multivariate Adjusted* 
  Na HR CI p 
Coffee     
No 47 1 ref  
Yes 91 0.66 0.46-0.96 0.03 
Coffee (cups)     
<1 46 1 ref  
1 6 0.39 0.17-0.92 0.03 
2-3 28 0.63 0.39-1.04 0.07 
4+ 16 0.70 0.39-1.26 0.23 
    0.11 
Regular Coffee    
No 70 1 ref  
Yes 63 0.72 0.51-1.03 0.07 
Regular (cups)    
<1 70 1 ref  
1 6 0.42 0.18-0.96 0.04 
2-3 29 0.85 0.54-1.32 0.47 
4+ 7 0.74 0.33-1.64 0.46 
    0.28 
Decaf Coffee     
No 92 1 ref  
Yes 24 0.79 0.50-1.24 0.31 
Decaf (cups)    
<1 92 1 ref  
1 3 0.45 0.14-1.40 0.16 
2-3 7 0.71 0.33-1.54 0.39 
4+ 1 -- -- -- 
    0.15 
Tea     
No 110 1 ref  
Yes 22 1.05 0.66-1.67 0.83 
Tea (cups)     
<1 110 1 ref  
1 5 0.93 0.38-2.28 0.87 
2+ 15 1.48 0.86-2.54 0.16 
        0.20 
a – Number of melanoma diagnoses in each group 
* - Adjusted for age, height, education, income, alcohol, smoke, region, aspirin, history of non-
melanoma skin cancer, sunscreen use, skin reaction, and summer sun exposure in thirties  
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APPENDIX 
DISTRIBUTION OF COVARIATES ACCORDING TO TEA 
 
 
          <1 cup/day 1 cup/day 2+ cups/day   
  Number (%) Number (%) Number (%) 
p-
value 
Age 
       50-54 6318 13.0 946 11.5 11144 13.1 <0.001 
55-59 9147 18.8 1452 17.7 1585 18.1 
 60-69 21672 44.6 3696 45.0 3885 44.5 
 70-79 11472 23.6 2125 25.9 2127 24.3 
 Education 
       high school or less 9512 19.7 1522 18.7 1807 20.8 0.008 
some college 17480 36.2 3038 37.2 3173 36.6 
 bachelors 11956 24.8 2016 24.7 2040 23.5 
 graduate degree 9316 19.3 1583 19.4 1652 19.1 
 Income 
       <$20000 5874 13.0 1011 13.2 1099 13.5 <0.001 
$20000-49999 19688 43.6 3390 44.2 3590 44.2 
 $50000-99999 14017 31.0 2371 30.9 2573 31.7 
 >$100000 5622 12.4 902 11.8 859 10.6 
 BMI (kg/m^2) 
       <25 20683 43.0 3638 44.7 3635 42.0 <0.001 
25-29.99 16288 33.9 2799 34.4 3003 34.7 
 30+ 11125 23.1 1697 20.9 2011 23.3 
 WHR 
       <0.75 12329 25.5 2096 25.6 2155 24.8 0.033 
0.75-0.85 24463 50.6 4238 51.8 4423 50.8 
 >0.85 11517 23.8 1846 22.6 2128 24.4 
 Height 
       <158 (Q1) 12201 25.3 2280 28.0 2307 26.6 <0.001 
158-162.1 (Q2) 11802 24.5 2031 24.9 2123 24.5 
 162.2-166.3 (Q3) 12153 25.2 1992 24.4 2130 24.6 
 >166.3 (Q4) 12091 25.1 1849 22.7 2103 24.3 
 Alcohol 
       Non-Drinkers 17969 37.0 2846 34.7 3498 40.1 <0.001 
<3 per week 17068 35.2 3200 39.0 3180 36.4 
 3-7 per week 6360 13.1 1088 13.3 1002 11.5 
 >7 per week 7163 14.8 1072 13.1 1054 12.1 
 Exercise per week 
       None 6840 14.1 1016 12.4 1264 14.5 <0.001 
<60 minutes 6089 12.6 1006 12.3 1141 13.1 
 60-150 minutes 11127 23.0 1983 24.2 2121 24.4 
 >150 minutes 24358 50.3 4178 51.1 4172 48.0 
 Region 
       Northeast 11131 22.9 2785 33.9 2531 29.0 <0.001 
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South 10885 22.4 2048 24.9 2594 29.7 
 Midwest 12333 25.4 1471 17.9 1533 17.5 
 West 14260 29.3 1915 23.3 2083 23.8 
 Hormone Use 
       Never 12888 27.0 2327 28.7 2469 28.7 <0.001 
Ever 34906 73.0 5769 71.3 6137 71.3 
 Smoke 
       Never 23378 48.7 4370 53.9 4560 52.9 <0.001 
Past 21725 45.3 3394 41.8 3565 41.3 
 Current 2905 6.1 350 4.3 504 5.8 
 Any NSAID use 
       No 27617 56.8 4642 56.5 4859 55.6 0.100 
Yes 20991 43.2 3577 43.5 3882 44.4 
 Aspirin 
       No 37797 77.8 6339 77.1 6735 77.1 0.195 
Yes 10811 22.2 1880 22.9 2006 23.0 
 Sunscreen Use 
       No 20520 47.3 3131 42.8 3662 47.1 <0.001 
Yes 22913 52.8 4192 57.2 4115 52.9 
 Skin Reaction 
       no burn/tan 15686 36.4 2605 35.5 2687 34.8 <0.001 
burn/tan 11204 25397.0 1864 25.4 1803 23.3 
 burn/tan slightly 11540 26.8 2017 27.5 2188 28.3 
 burn/no tan 4710 10.9 846 11.5 1049 13.6 
 Summer/day during childhood 
      <=120 minutes 12504 28.5 2145 28.9 2197 28.0 0.471 
>120 minutes 31343 71.5 5287 71.1 5654 72.0 
 Summer/day during Teens 
      <=120 minutes 17354 39.6 3010 40.5 3061 39.1 0.16 
>120 minutes 26439 60.4 4414 59.5 4778 61.0 
 Summer/day during thirties 
      <=120 minutes 29842 68.1 5068 68.2 5344 68.1 0.976 
>120 minutes 13997 31.9 2364 31.8 2499 31.9 
 Other season/day during childhood 
     <=120 minutes 27661 63.4 4727 63.9 4829 61.9 0.018 
>120 minutes 15986 36.6 2669 36.1 2975 38.1 
 Other season/day during 
teens 
      <=120 minutes 30547 70.0 5232 70.9 5307 67.9 <0.001 
>120 minutes 13096 30.0 2150 29.1 2510 32.1 
 Other season/day during thirties 
     <=120 minutes 36355 83.2 6161 83.3 6395 81.8 0.008 
>120 minutes 7342 16.8 1239 16.7 1424 18.2 
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